1. Home
  2. Directory
  3. Louisiana
  4. Chalmette
  5. General Practice
  6. NPI Profile
  7. Prescriptions 1043385693

SCOTT GERARD CONKLIN M.D.
Prescription History 1043385693
General Practice in Chalmette, LA


Quality Rating: 91.96 out of 100 score

NPI Status: Active since November 21, 2006

Contact Information

619 E JUDGE PEREZ DR
CHALMETTE, LA
ZIP 70043
Phone: (504) 309-8837
Fax: (504) 309-8954

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SCOTT GERARD CONKLIN M.D., an active General Practice specialist practicing in Chalmette, LA. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 68 documented patient claims. Among these therapy options, the most frequently utilized medication is Ibuprofen, which accounts for 24 claims alone.

Medication Index

H
I
M
No matching medications currently found on file.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 87
LA State Average Benchmarks
Peer Average Claims114.0
Peer Average 30-Day Fills114.8
Peer Average Days Supply2,386
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.6% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $86.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.11

State Avg Cost Per Claim

$17.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Ibuprofen

Generic Formulation: IbuprofenSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 146
LA State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills37.1
Peer Average Days Supply714
Conservative Utilization

This provider writes prescriptions for this formulation 29.4% less frequently than the standard regional baseline metric for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $77.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.24

State Avg Cost Per Claim

$8.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties

Therapeutic Applications

Ibuprofen is used to help relieve mild to moderate pain. When used with an opioid (such as morphine), it may be used to relieve moderate to severe pain. It is also used to reduce fever. Ibuprofen is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 115
LA State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills38.9
Peer Average Days Supply884
Conservative Utilization

This provider writes prescriptions for this formulation 32.4% less frequently than the standard regional baseline metric for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $123.22 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.36

State Avg Cost Per Claim

$9.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like SCOTT GERARD CONKLIN M.D. provides transparency into local medical care patterns within Chalmette, LA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **General Practice** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.